4 Merger and Acquisitions Stock Stories Ready for a Thursday Appraisal

GlaxoSmithKline plc (NYSE:GSK): Current price $51.49

Knowledgeable sources say that Suntory Beverage & Food of Japan is in advanced negotiations to acquire Glaxo’s Lucozade and Ribena drinks for over $1.6 billion in a deal that would avert an auction of the brands. An agreement might be announced in the next few days, according to one of the sources on Thursday. GlaxoSmithKline, the United Kingdom’s number-one drugmaker, announced plans in April to divest Lucozade and Ribena — which are top sellers in Britain — but do not have worldwide appeal as the firm tries to make its consumer health business more centered.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

GSK 20130905

Parkway Properties, Inc. (NYSE: PKY): Current price $16.07

On Thursday, Parkway Properties and Thomas Properties Group, Inc. signed a definitive merger agreement through which Thomas Properties will merge with Parkway in a stock-for-stock transaction valued at roughly $1.2 billion. The merger was unanimously affirmed by the boards of each company, following receipt of fairness opinions, and the transaction should close by the end of the fourth quarter, subject to the approval of stockholders of both parties, receipt of certain third party consents, and other usual closing conditions.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

PKY 20130905

Alliant Techsystems Inc. (NYSE:ATK): Current price $98.77

Alliant will purchase the designer, marketer, and distributor of branded sports optics, outdoor accessories and performance eyewear Bushnell Group Holdings, Inc. The Bushnell acquisition will build upon the buyer’s product offerings into crucial growth areas and the completed buyout would result in a comprehensive product offering in commercial and security ammunition, sporting arms, and accessories. The transaction is subject to regulatory approvals and the usual closing conditions. ATK expects to close the transaction in the third or fourth quarter of its Fiscal Year 2014.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

ATK 20130905

FactSet Research Systems Inc. (NASDAQ:FDS): Current price $106.14

FactSet, which supplies integrated financial information and analytical applications to the world investment community, announced Thursday that it has purchased Revere Data, LLC. The acquisition is not expected to have a material impact on fiscal 2014 diluted earnings per share.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

FDS 20130905

Don’t Miss: Here’s Where Most Tesla Model S Sedans are Parked and Why.

More Articles About:   , ,  

More from The Cheat Sheet